Dyslipidemia is one of the main modifiable cardiovascular risk factors. There is strong evidence for the efficacy of lipid-lowering drugs in secondary prevention, as well as in primary prevention for patients at high cardiovascular risk. In primary ...
Hypertriglyceridemia and HDL DeficiencyAbstract. The risks for atherosclerotic cardiovascular diseases (ASCVD) as well as acute pancreatitis raise with increasing plasma concentrations of triglycerides. Low levels of HDL-...